Trending Now
Fulcrum Therapeutics, Inc (NASDAQ: FULC) Says the Unveiled Proof-Of-Concept For FTX-6058...
Fulcrum Therapeutics, Inc (NASDAQ: FULC) has spoken about its ongoing Phase 1b trial of FTX-6058, whose goal is to develop a working...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
UNITY Biotechnology Inc (NASDAQ: UBX) Announces 12- and 18-Week Findings From...
UNITY Biotechnology Inc. (NASDAQ: UBX) has announced twelve- and eighteen-week findings from the Phase 2 BEHOLD trial of UBX1325, its seneolytic Bcl-xL inhibitor, in...
MAKE IT MODERN
LATEST REVIEWS
Zogenix (NASDAQ: ZGNX) Announces Sponsorship of a United Mitochondrial Disease Foundation...
Zogenix (NASDAQ: ZGNX) has announced that it is sponsoring a new no-cost gene testing program, the United Mitochondrial Disease Foundation Pilot Genetic Testing Project,...
MAKE IT MODERN
PERFORMANCE TRAINING
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) Commences Clinical Trials For REGN-COV2 As A Potential COVID-19 Vaccine
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) announced on Thursday that it kick-started REGN-COV2 clinical trials, aiming to test the antibody combination's ability to prevent COVID-19.
The announcement,...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) Releases Positive Third Phase BOSTON Study Data At The 2020...
Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has reported detailed data from the third phase BOSTON study that the company will present at this year’s American Society...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Commences Relacorilant’s Phase 3 Clinical Trial In Patients Suffering From...
Corcept Therapeutics Incorporated (NASDAQ:CORT) started phase 3 clinical study of Relacorilant in patients who suffer from Cushing's syndrome. As part of this study, the...
Cannabis Global, Inc. (OTCMKTS:MCTC) is Making a Unique Bet
One California cannabis company is making a very interesting bet and marching to the beat of its own drum: MCTC Holdings Inc (OTCMKTS:MCTC), now...
Electric Vehicle Stocks For the Win (WKHS, KULR, BYDDY, FCEL)
The rush to drive a new paradigm in the automobile space is already well underway, with the Biden administration announcing this week...
MAKE IT MODERN
